Leverage Shares 3x Long Moderna ETP (MRN3.L) Price

Leverage Shares 3x Long Moderna ETP is offered by Leverage Shares, a leading player in the field of passive investments.

The ISIN of Leverage Shares 3x Long Moderna ETP is XS3005160091.

The total expense ratio of Leverage Shares 3x Long Moderna ETP is 3.78%, which means that investors pay 378.00 USD per 10,000 USD in investment capital annually.

The ETF is listed in USD.

European investors may incur additional costs for currency exchange and transaction fees.

No, Leverage Shares 3x Long Moderna ETP does not comply with the EU UCITS investor protection directives.

Leverage Shares 3x Long Moderna ETP tracks the performance of the iSTOXX Leveraged 3x MRNA Index - Benchmark TR Net.

Leverage Shares 3x Long Moderna ETP is domiciled in IE.

The fund was launched on 12/14/2021.

The Leverage Shares 3x Long Moderna ETP mainly invests in Healthcare companies.

The NAV of Leverage Shares 3x Long Moderna ETP amounts to 18.28 M USD.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.